Securities code: 000516 securities abbreviation: Xi’An International Medical Investment Company Limited(000516) Announcement No.: 2021-069 Xi’An International Medical Investment Company Limited(000516) suggestive announcement on the implementation of other risk warnings on the company’s shares and the suspension of the company’s shares
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. Xi\’an high tech hospital (hereinafter referred to as “high tech hospital”) and Xi\’an Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as “Central Hospital”) under Xi’An International Medical Investment Company Limited(000516) (hereinafter referred to as “the company”) received the notice of Xi\’an Health Commission on the handling of Xi\’an high tech hospital and Xi\’an Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as “notice”) on January 13, 2022, After the study of Xi\’an Health Committee, the two hospitals were closed for rectification for 3 months, and reopened after the rectification was qualified.
According to article 9.8.1 of the Listing Rules of Shenzhen Stock Exchange (revised in 2022), this event triggered the corresponding situation of “other risk warnings for the shares of listed companies”.
2. The trading of the company’s shares has been suspended for one day since the opening of the market on January 14, 2022 and resumed since the opening of the market on January 17, 2022.
3. Other risk warnings have been implemented for the company’s shares since the opening of the market on January 17, 2022. The abbreviation of the company’s shares has been changed from ” Xi’An International Medical Investment Company Limited(000516) ” to “St Guoyi”, the stock code is still “000516”, and the rise and fall of the stock trading day is limited to 5%.
1、 Stock type, abbreviation, securities code and the starting date of risk warning
1. Stock type: RMB common stock a share
2. Stock abbreviation: changed from ” Xi’An International Medical Investment Company Limited(000516) ” to “St Guoyi”
3. Securities code: still “000516”
4. Start date of other risk warning: January 17, 2022
The trading of the company’s shares was suspended for one day on January 14, 2022. Since the resumption of trading on January 17, 2022, the company’s shares have been subject to other risk warnings.
5. After the implementation of risk warning, the daily rise and fall of the company’s stock price is limited to 5%.
2、 Application of other risk warnings
After the current round of epidemic in Xi’an, due to the mechanical implementation of relevant epidemic prevention policies in front of the company’s subordinate high-tech hospitals and central hospitals, the rescue and diagnosis and treatment of acute and dangerous patients were delayed, which aroused widespread concern of public opinion and caused serious consequences. After the study of Xi’an Health Committee, the two hospitals were closed for rectification for 3 months, and reopened after the rectification was qualified.
According to article 9.8.1 of the Listing Rules of Shenzhen Stock Exchange (revised in 2022), this event triggered the corresponding situation of “other risk warnings for the shares of listed companies”.
3、 Opinions and specific measures of the board of directors on other risk warnings implemented
For the occurrence of this incident, the company feels extremely sad, guilty and remorse, and expresses deep apology to the patients and their families and the public. It will make every effort to deal with the postoperative rehabilitation treatment, appeasement and compensation of the patients and their families, deeply reflect, immediately rectify, learn lessons, and hold the relevant responsible persons accountable. During the period of covid-19 pneumonia epidemic prevention and control, the two hospitals mechanically implemented relevant epidemic prevention policies, exposing weak overall awareness, false work style, weak sense of responsibility and lack of humanistic care.
The board of directors of the company will take measures to eliminate risks, fully urge the subordinate high-tech hospitals and central hospitals of the company to close down for rectification from now on in strict accordance with the requirements of the circular, and properly handle the patient counseling, staff training, internal rectification and other related work under the guidance of the provincial and Municipal Health Commission. Guided by the spirit of the important instructions of Xi Jinping general secretary on people first and life first, adhere to the problem orientation, further strengthen the medical admission management of its medical institutions, compact the responsibility of medical service guarantee, optimize the diagnosis and treatment process, smooth the medical links, strengthen personnel training, improve the sense of responsibility of all staff, and resolutely put an end to any such incidents.
Under the situation that the anti epidemic and medical resources are still tight, while handling all the work in the hospital during the period of closure for rectification, the hospital continues to organize medical staff to complete the tasks of supporting covid-19 designated hospital patient treatment and community nucleic acid sampling, and coordinate the epidemic prevention and control, hospital service optimization and management improvement.
The company will strive to take various measures to meet the requirements of revoking other risk warnings as soon as possible. After the corresponding circumstances are eliminated, the company will timely announce and apply to Shenzhen stock exchange for revoking other risk warnings.
4、 During the implementation of other risk warning, the company will receive investor consultation through telephone, e-mail and interactive communication. The contact information is as follows:
1. Tel.: 029-88330516
2. Email: [email protected].
The company will fulfill the obligation of information disclosure in time according to the follow-up progress of the suspension of business for rectification. The information disclosure media designated by the company are securities times, China Securities News, Shanghai Securities News, securities daily and cninfo. Com. The information about the company shall be subject to the information published in the above designated media. Please invest rationally and pay attention to risks.
It is hereby announced.
Xi’An International Medical Investment Company Limited(000516) board of directors January 14, 2002
